Pharmacology & ToxicologyInternational Journal of Molecular SciencesPeer-reviewed
Towards new AQP4 inhibitors: ORI-TRN-002
Michael Thormann, Nadine Traube, Nasser Yehia…·Trine Lisberg Toft‐Bertelsen
This paper identifies ORI-TRN-002 as a novel AQP4 inhibitor with improved solubility and low protein binding, potentially useful for antiedema therapy.
5 citations